Search

Your search keyword '"Jacobs, Joshua"' showing total 1,976 results

Search Constraints

Start Over You searched for: Author "Jacobs, Joshua" Remove constraint Author: "Jacobs, Joshua"
1,976 results on '"Jacobs, Joshua"'

Search Results

1. Direct recordings of grid-like neuronal activity in human spatial navigation

5. Predicting chronic postsurgical pain: current evidence and a novel program to develop predictive biomarker signatures

11. Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study

16. A consensus statement on detection of hippocampal sharp wave ripples and differentiation from other fast oscillations

17. Multi-Site Observational Study to Assess Biomarkers for Susceptibility or Resilience to Chronic Pain: The Acute to Chronic Pain Signatures (A2CPS) Study Protocol

18. Judaism

21. Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial

23. Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study

28. Judaism

29. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

31. Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

35. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials

36. Howard S. An: 2023 International Society for the Study of the Lumbar Spine Wiltse Lifetime Achievement Award

38. Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial

41. Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States

42. Garadacimab For Hereditary Angioedema Prophylaxis In Adolescents: Efficacy And Safety From The Phase 3 (VANGUARD) Study And Open-Label Extension (Second Interim Analysis)

43. Integrated Safety And Efficacy Of Garadacimab For Hereditary Angioedema Prophylaxis Across 3 Clinical Trials: Phase 2, Pivotal Phase 3, And Open-Label Extension Studies

45. Association Between Self‐Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)

49. Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)

Catalog

Books, media, physical & digital resources